China Resources Double-Crane Pharmaceutical Co.,Ltd.

¥16.07As of Sun 8 Nov 2026, 12:00 UTC
SSE:600062Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 2.22%
Div yield 2.98%
ROE 12.48%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.01)
PE TTM 10.69
TSR TTM (14.64%)
Mkt cap ¥16.60B
ROIC 10.48%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥15
(3.85%)
(73.02%)
Hold 8|5|5|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.16
0.15
0.17
0.19
15.96%
12.13%
15.09%
21.48%
Revenue¥M
854.3
894.3
883.7
861.7
1.09%
1.14%
(0.52%)
(1.15%)
Peers (US$2.488B)
Cap (US$)
PE
2.349B
56.11x
2.334B
28.62x
2.327B
12.89x
Capital
TTM
5Y
10Y
Leveragex
0.791
0.077
0.078
EBIT/Intx
1.918
0.117
0.128
Own earn%
98.71
(86.73)
(79.39)
Sh yield%
42.78
8.53
8.96
Owners
Insiders/Inst%
5.82
56.59
Short interest%
2.07
SBC / revenue%
5.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
13–19
$1 testx
−0.1
Incr. ROIC%
1